Cognitive Remediation of Autobiographical Memory in Schizophrenia Using SenseCam®
RéMABSchiz
REMEDIATION COGNITIVE DE LA MÉMOIRE AUTOBIOGRAPHIQUE DANS LA SCHIZOPHRENIE AU MOYEN DE SENSECAM
1 other identifier
interventional
80
1 country
1
Brief Summary
The aim of the study is to assess the efficiency of SenseCam® in patients with schizophrenia by comparing two cognitive remediation methods of autobiographical memory.Patients and control participants will be invited to carry SenseCam® during 7 hours per day minimum and for 4 successive days. Each ending day when carry SenseCam®, they will be asked to go to the laboratory where 4 types of interventions will be successively done according to the randomization: 1) a simple visual retrospective procedure (SVR), 2) a visual retrospective procedure coupled with a specific cueing intervention (VR-SC), 3) a verbal retrospective (VbR) and 4) no intervention (control condition).The testing phase will take place 14 days after the last day of data collection and will consist in a cued recall task and a recognition task using the pictures obtained by the SenseCam® of the participants.According to our hypotheses, the vividness of memories will be higher in events subjected to the VR-SC procedure than in events subjected to the SVR and VbR procedures. This effect is expected for both patients with schizophrenia and controls participants. Since strategies to enrich memory details will be explicitly given to the patients when using the VR-SC procedure, we assume that patients will be able to normalize their scores.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started May 2014
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 25, 2013
CompletedFirst Posted
Study publicly available on registry
January 16, 2014
CompletedStudy Start
First participant enrolled
May 1, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2019
CompletedAugust 28, 2018
August 1, 2018
5.3 years
June 25, 2013
August 24, 2018
Conditions
Outcome Measures
Primary Outcomes (1)
Specificity of memories recovered by using the SenseCam camera during the trial
Test the effectiveness of two techniques of cognitive remediation of autobiographical memory using an innovative tool called SenseCam.This specificity will be evaluated by the experimenter by scoring wealth in detail memories reported during the cued recall task
1 month
Study Arms (2)
patient
OTHERComplete questionary remembering the day
healthy volunteers
OTHER\- Complete questionary, remembering the day
Interventions
Test the effectiveness of two techniques of cognitive remediation of autobiographical memory using an innovative tool called SenseCam ® for patient
Eligibility Criteria
You may qualify if:
- for both patients and controls
- male or female willing to participate and who have signed up the legal document
- under the protection of health insurancefor patients only
- schizophrenia or schizo-affective disorder according to the DSM-IV
- TR criteria
- clinically stable for at least 2 monthsfor controls only
- no psychiatric history
You may not qualify if:
- for both patients and controls
- current severe or unstable somatic illness
- neurological history (epilepsia, brain injury, brain surgery…)
- current substance use disorder (DSM-IV-TR)
- current major depressive disorder (DSM-IV-TR)
- mental retardation (IQ \< 70)
- pregnancy, breast feeding
- current legal controlfor patients only
- treatment comprising benzodiazepines
- benzodiazepines intake during the last 3 weeksfor controls only
- psychotropic intake during the last 3 weeks
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Berna
Strasbourg, 67000, France
Study Officials
- PRINCIPAL INVESTIGATOR
Fabrice Berna, MD
Les Hôpitaux Universitaires de Strasbourg
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 25, 2013
First Posted
January 16, 2014
Study Start
May 1, 2014
Primary Completion
September 1, 2019
Study Completion
December 1, 2019
Last Updated
August 28, 2018
Record last verified: 2018-08